Spectrum of PD-1 and PD-L1 inhibitor cutaneous adverse events in skin of color: a retrospective, single-institutional study in an urban community.

Ngo, Tracy; Hossain, Claudia; Guzman, Anthony K; Halmos, Balazs; Balagula, Yevgeniy; McLellan, Beth

Ngo, Tracy; Hossain, Claudia; Guzman, Anthony K; Halmos, Balazs; Balagula, Yevgeniy; McLellan, Beth.

Afiliação

Ngo T; Department of Internal Medicine, Division of Dermatology, Albert Einstein College of Medicine, Bronx, NY, USA.
Hossain C; Department of Internal Medicine, Division of Dermatology, Albert Einstein College of Medicine, Bronx, NY, USA.
Guzman AK; Department of Internal Medicine, Division of Dermatology, Albert Einstein College of Medicine, Bronx, NY, USA.
Halmos B; Department of Oncology, Albert Einstein College of Medicine, Bronx, NY, USA.
Balagula Y; Department of Internal Medicine, Division of Dermatology, Albert Einstein College of Medicine, Bronx, NY, USA.
McLellan B; Department of Internal Medicine, Division of Dermatology, Albert Einstein College of Medicine, Bronx, NY, USA.

Acta Oncol ; 60(4): 559-563, 2021 Apr.

Article em En | MEDLINE | ID: mdl-33522846

Assuntos

Inibidores de Checkpoint Imunológico; Receptor de Morte Celular Programada 1; Humanos; Nivolumabe; Estudos Retrospectivos; Pigmentação da Pele

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Receptor de Morte Celular Programada 1 / Inibidores de Checkpoint Imunológico Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Acta Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google